These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5380778)

  • 1. [Infections of the genitourinary system. Treatment with cephalothin and cephaloridine].
    Evans JG
    Prensa Med Mex; 1969; 34(5):Suppl:78-83. PubMed ID: 5380778
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefazolin vs cephalothin and cephaloridine. A comparison of their clinical pharmacology.
    Regamey C; Gordon RC; Kirby WM
    Arch Intern Med; 1974 Mar; 133(3):407-10. PubMed ID: 4811478
    [No Abstract]   [Full Text] [Related]  

  • 3. [Administration of cephalothin and cephloridine in uremic patients with hemodialysis].
    Takayasu H; Kitagawa R; Miyamura R; Koiso K; Kano S
    Saishin Igaku; 1971 Jun; 26(6):1173-7. PubMed ID: 5098182
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nil nocere. On the problem of the nephrotoxicity of cephaloridine].
    Straube W; König K
    Munch Med Wochenschr; 1969 Mar; 111(12):665-9. PubMed ID: 5819271
    [No Abstract]   [Full Text] [Related]  

  • 5. [Body fluid concentration of parenterally administered cephalosporin C derivatives].
    Seiga K; Yamaji K; Sugiyama Y
    Jpn J Antibiot; 1972 Aug; 25(4):233-8. PubMed ID: 4539470
    [No Abstract]   [Full Text] [Related]  

  • 6. Cephaloridine and the kidneys.
    Benner EJ
    J Infect Dis; 1970; 122(1):104-5. PubMed ID: 5433704
    [No Abstract]   [Full Text] [Related]  

  • 7. [The study of pharmacokinetics of antimicrobial agents in new born infants. I. Transition of serum concentration after intravenous administration of cephalosporin C analogues (author's transl)].
    Kurosu Y
    Jpn J Antibiot; 1979 Oct; 32(10):1009-16. PubMed ID: 513282
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vitro sensitivity to cephaloridine of 466 strains of gram-negative bacilli].
    Brisou J; Rautlin de la Roy Y DE; Denis F; Sudre C
    Pathol Biol (Paris); 1969 Oct; 17(19):845-7. PubMed ID: 4907920
    [No Abstract]   [Full Text] [Related]  

  • 9. Cephalothin v. cephaloridine.
    Drug Ther Bull; 1969 Dec; 7(26):101-2. PubMed ID: 5359967
    [No Abstract]   [Full Text] [Related]  

  • 10. [Correlation of susceptibility of organisms, dosage and clinical effects, observed in dose-response-curve in cephaloridine treatment of drug-resistant urinary tract infections].
    Seiga K
    Saishin Igaku; 1968 Nov; 23(11):2384-92. PubMed ID: 5715167
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of urinary infection by means of a single dose of cephaloridine.
    Brumfitt W; Faiers MC; Franklin IN
    Postgrad Med J; 1970 Oct; ():Suppl:65-9. PubMed ID: 4922710
    [No Abstract]   [Full Text] [Related]  

  • 12. Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease.
    Ratzan KR; Ruiz C; Irvin GL
    Antimicrob Agents Chemother; 1974 Oct; 6(4):426-31. PubMed ID: 4157339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre dose-response trial with cephaloridine.
    Foord RD
    Postgrad Med J; 1967 Aug; 43():Suppl 43:63-9. PubMed ID: 4861120
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of cephalothin, cephaloridine, cephalexin and cephaloglycin in streptococcal infections in monkeys.
    Saslaw S; Carlisle HN
    Am J Med Sci; 1969 Jun; 257(6):395-407. PubMed ID: 4978251
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cephaloridine. Clinical study on 100 cases].
    Rechniewsky C; Gherardi CR; Mazzei CM; Diez E
    Prensa Med Argent; 1968 Mar; 55(4):187-93. PubMed ID: 5741630
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative serum levels and urinary recovery of cefazolin, cephaloridine, and cephalothin in man.
    Cahn MM; Levy EJ; Actor P; Pauls JF
    J Clin Pharmacol; 1974 Jan; 14(1):61-6. PubMed ID: 4588120
    [No Abstract]   [Full Text] [Related]  

  • 17. Absence of nephrotoxicity during cephaloridine therapy for urinary-tract infection.
    Winchester JF; Kennedy AC
    Lancet; 1972 Sep; 2(7776):514-6. PubMed ID: 4115572
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind comparison of cephacetrile with cephalothin-cephaloridine.
    Jackson GG; Riff LJ; Zimelis VM; Daood M; Youssuf M
    Antimicrob Agents Chemother; 1974 Mar; 5(3):247-54. PubMed ID: 4599121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basic and clinical evaluation of cephaloridine in obstetrics and gynecology].
    Takase Z; Ishikawa A; Shirota H; Kuwashima U; Mizutani K
    Sanfujinka No Jissai; 1967 May; 16(5):386-91. PubMed ID: 5630533
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacodynamics of cephaloridine and cephalothin combined with sulfalene in rabbits].
    Bobrov VI; Beletskaia GT; Iakovlev VP
    Antibiotiki; 1984 Nov; 29(11):823-5. PubMed ID: 6524880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.